Who Owns Oruka Therapeutics Stock?
NASDAQ: ORKAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 116.60%
- Institutions (% of float)
- 118.08%
- Held by insiders
- 1.26%
- Institutional holders
- 344
- Institutions 98.7%
- Insiders 1.3%
- Public and other 0.0%
Who owns Oruka Therapeutics stock?
Institutional investors own about 116.6% of Oruka Therapeutics's shares, spread across 344 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.26% of ORKA.
The largest institutional holders are FMR, LLC (13.68%), Blackrock Inc. (7.54%) and Venrock Adviser, LLC (6.27%). Together, the top 10 institutions control 56.7% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ORKA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ORKA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 9.06M | 13.68% | +21.9% |
| Blackrock Inc. | 4.99M | 7.54% | +41.5% |
| Venrock Adviser, LLC | 4.15M | 6.27% | 0.0% |
| Fairmount Funds Management LLC | 3.71M | 5.60% | 0.0% |
| Capital World Investors | 3.40M | 5.14% | +100.0% |
| RTW Investments LP | 3.14M | 4.74% | +52.5% |
| State Street Corporation | 2.67M | 4.04% | +65.7% |
| Vanguard Capital Management LLC | 2.36M | 3.57% | +27.0% |
| Paradigm Biocapital Advisors LP | 2.14M | 3.24% | -7.6% |
| Deep Track Capital, Lp | 1.93M | 2.91% | -5.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ORKA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.72M | 2.60% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.64M | 2.47% |
| SmallCap World Fund Inc | 1.53M | 2.31% |
| New Economy Fund | 1.32M | 2.00% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.29M | 1.95% |
| iShares Trust-iShares Russell 2000 ETF | 1.29M | 1.95% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 880.00K | 1.33% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 737.39K | 1.11% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 685.72K | 1.04% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 580.95K | 0.88% |
Frequently asked questions
Who is the largest shareholder of Oruka Therapeutics?
FMR, LLC is the largest institutional shareholder of ORKA, owning 13.68% of shares outstanding (9.06M shares) as of its latest 13F filing.
What percentage of Oruka Therapeutics is owned by institutions?
Institutions own about 116.6% of ORKA shares and 118.1% of the public float.
How much of Oruka Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.26% of ORKA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.